Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications

INTERNATIONAL JOURNAL OF CREATIVE RESEARCH THOUGHTS - IJCRT (IJCRT.ORG)

International Peer Reviewed & Refereed Journals, Open Access Journal

IJCRT Peer-Reviewed (Refereed) Journal as Per New UGC Rules.

ISSN Approved Journal No: 2320-2882 | Impact factor: 7.97 | ESTD Year: 2013

Call For Paper - Volume 14 | Issue 3 | Month- March 2026

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(CrossRef DOI)

Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

CAR T Cell Therapy: Breakthroughs, Challenges, and Future Prospects.

  Authors

  Tushar Prabhakar Petewar,  Rosalin Manohar Alexander

  Keywords

Cancer, Carcinoma, Uncontrolled Cell Growth, Tumor, Neoplasm.

  Abstract


Cancers are a diverse group of diseases characterized by uncontrolled cell growth, which can invade surrounding tissues or spread throughout the body. They are classified as neoplasms or tumors, formed by cells that undergo unregulated growth, often resulting in masses or lumps. Cancers are categorized based on the type of cell that the tumor cells resemble. Key types include: Carcinoma: Cancers arising from epithelial cells, including common forms in the breast, prostate, lung, pancreas, and colon. Most are adenocarcinomas, which have gland-like characteristics. Sarcoma: These originate from connective tissues like bone, cartilage, fat, and nerve. Lymphoma and leukemia: These arise from blood-forming cells, with lymphomas maturing in lymph nodes and leukemias in the blood. Germ cell tumors: Derived from pluripotent cells, usually found in the testis or ovary. Blastoma: Arising from immature precursor cells or embryonic tissue. Before CAR T-cell therapy, standard cancer treatments included surgery, radiation, chemotherapy, immunotherapy, and targeted therapy. While effective for many, these treatments often have limitations, highlighting the need for innovative approaches like CAR T- cell therapy. CAR T-cell therapy provides distinct advantages, utilizing a patient's reprogrammed T cells to specifically target cancer cell antigens. This personalized method leads to more effective outcomes and fewer side effects compared to conventional therapies. It has demonstrated significant efficacy in blood cancers and shows promise in solid tumors as well. CAR T-cell therapy involves the creation of chimeric antigen receptors (CARs), which include an antigen-binding domain, a hinge region, a transmembrane domain, and intracellular signaling domains. There are three generations of CARs, each offering enhancements over the previous one. Recent innovations, like ROR1 CAR T-cell therapy, have demonstrated promise in effectively inducing tumor cell death, representing a significant advancement in cancer treatment.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2412747

  Paper ID - 274621

  Page Number(s) - g767-g787

  Pubished in - Volume 12 | Issue 12 | December 2024

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Tushar Prabhakar Petewar,  Rosalin Manohar Alexander,   "CAR T Cell Therapy: Breakthroughs, Challenges, and Future Prospects.", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.12, Issue 12, pp.g767-g787, December 2024, Available at :http://www.ijcrt.org/papers/IJCRT2412747.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper March 2026
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A digital object identifier by DOI.org How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer